{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T06:10:04Z","timestamp":1648793404255},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1007\/bf03347774","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T11:41:54Z","timestamp":1396611714000},"page":"775-782","source":"Crossref","is-referenced-by-count":1,"title":["Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma"],"prefix":"10.1007","volume":"17","author":[{"given":"K.","family":"Iyota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Matsuzuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Okabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03347774_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 253: 49, 1991.","journal-title":"Science"},{"key":"BF03347774_CR2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1589764","volume":"256","author":"SE Kern","year":"1992","unstructured":"Kern S.E., Pietenpol J.A., Thigalingam S., Seymour A., Kinzler K.W., Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827, 1992.","journal-title":"Science"},{"key":"BF03347774_CR3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","volume":"329","author":"CC Harris","year":"1993","unstructured":"Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329: 1318, 1993.","journal-title":"N. Engl. J. Med."},{"key":"BF03347774_CR4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0092-8674(91)90560-L","volume":"65","author":"J Bargonetti","year":"1991","unstructured":"Bargonetti J., Friedman P.N., Kern S.E., Vogelstein B., Prives C. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell. 65: 1083, 1991.","journal-title":"Cell"},{"key":"BF03347774_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/358083a0","volume":"358","author":"G Farmer","year":"1992","unstructured":"Farmer G., Bargonetti J., Zhu H., Friedman P., Prywes R., Prives C. Wild-type p53 activates transcription in vitro. Nature 358: 83, 1992.","journal-title":"Nature"},{"key":"BF03347774_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","volume":"351","author":"AJ Levine","year":"1991","unstructured":"Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature 351: 453, 1991.","journal-title":"Nature"},{"key":"BF03347774_CR7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","volume":"362","author":"SW Lowe","year":"1993","unstructured":"Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847, 1993.","journal-title":"Nature"},{"key":"BF03347774_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","volume":"362","author":"AR Clarke","year":"1993","unstructured":"Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849, 1993.","journal-title":"Nature"},{"key":"BF03347774_CR9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.2047879","volume":"252","author":"SE Kern","year":"1991","unstructured":"Kern S.E., Kinzler K.W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science 252: 1708, 1991.","journal-title":"Science"},{"key":"BF03347774_CR10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/363281a0","volume":"363","author":"DH Mack","year":"1993","unstructured":"Mack D.H., Vartikar J., Pipas J.M., Laimins L.A. Specific repression of TATA-mediated but not intiator-mediated transcription by wild-type p53. Nature 363: 281, 1993.","journal-title":"Nature"},{"key":"BF03347774_CR11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0092-8674(92)90562-Q","volume":"71","author":"TR Hupp","year":"1992","unstructured":"Hupp T.R., Meek D.W., Midgley C.A., Lane D.P. Regulation of the specific DNA binding function of p53. Cell 71: 875, 1992.","journal-title":"Cell"},{"key":"BF03347774_CR12","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1073\/pnas.89.24.12028","volume":"89","author":"E Seto","year":"1992","unstructured":"Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Lavine A.J., Shenk T. Wild-type p53 binds to TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89: 12028, 1992.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03347774_CR13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","volume":"69","author":"J Momand","year":"1992","unstructured":"Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237, 1992.","journal-title":"Cell"},{"key":"BF03347774_CR14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","volume":"362","author":"JD Oliner","year":"1993","unstructured":"Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362: 857, 1993.","journal-title":"Nature"},{"key":"BF03347774_CR15","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1002\/j.1460-2075.1992.tb05434.x","volume":"11","author":"P Hainaut","year":"1992","unstructured":"Hainaut P., Milner J. Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBO J. 11: 3513, 1992.","journal-title":"EMBO J"},{"key":"BF03347774_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/320084a0","volume":"320","author":"M Isobe","year":"1986","unstructured":"Isobe M., Emanuel B.S., Oren M., Croce C.M. Localization of gene for human p53 tumor antigen to band 17p13. Nature 320: 84, 1986.","journal-title":"Nature"},{"key":"BF03347774_CR17","first-page":"945","volume":"5","author":"T Soussi","year":"1990","unstructured":"Soussi T., Fromentel C.C., May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5: 945, 1990.","journal-title":"Oncogene"},{"key":"BF03347774_CR18","first-page":"1693","volume":"6","author":"PA Wright","year":"1991","unstructured":"Wright P.A., Lemoine N.R., Goretzki P.E., Wyllie F.S., Bond J., Hughes C., Roher H-D., Williams E.D., Wynford-Thomas D. Mutations of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumors. Oncogene 6: 1693, 1991.","journal-title":"Oncogene"},{"key":"BF03347774_CR19","first-page":"1369","volume":"52","author":"T Ito","year":"1992","unstructured":"Ito T., Seyama T., Mizuno T., Tsuyama N., Hayashi T., Hayashi Y., Dohi K., Nakamura N., Akiyama M. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res. 52: 1369, 1992.","journal-title":"Cancer Res."},{"key":"BF03347774_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI116168","volume":"91","author":"JA Fagin","year":"1993","unstructured":"Fagin JA, Matsuo K., Karmakar A., Chen D.L., Tang S-H., Koeffler H.P. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J. Clin. Invest. 91: 179, 1993.","journal-title":"J. Clin. Invest."},{"key":"BF03347774_CR21","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1172\/JCI116385","volume":"91","author":"R Donghi","year":"1993","unstructured":"Donghi R., Longoni A., Pilotti S., Michieli P., Porta G.D., Pierotti M.A. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest. 91: 1753, 1993.","journal-title":"J. Clin. Invest."},{"key":"BF03347774_CR22","first-page":"1054","volume":"77","author":"M Zou","year":"1993","unstructured":"Zou M., Shi Y., Farid N.R. p53 mutaions in all stages of thyroid carcinomas. J. Clin. Endocrinol. Metab. 77: 1054, 1993.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347774_CR23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1182\/blood.V77.6.1153.1153","volume":"77","author":"K Sugimoto","year":"1991","unstructured":"Sugimoto K., Toyoshima H., Sakai R., Miyagawa K., Hagisawa K., Hirai H., Ishikawa F., Takaku F. Mutations of the p53 gene in lymphoid leukemia. Blood 77: 1153, 1991.","journal-title":"Blood"},{"key":"BF03347774_CR24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0006-291X(05)80309-2","volume":"183","author":"K Kondo","year":"1992","unstructured":"Kondo K., Umemoto A., Akimoto S., Uyama T., Hayashi K., Ohnishi Y., Monden Y. Mutations in the p53 tumor suppressor gene in primary lung cancer in Japan. Biochem. Biophys. Res. Commun. 183: 1139, 1992.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03347774_CR25","first-page":"153","volume-title":"PCR protocols","author":"MA Innis","year":"1990","unstructured":"Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. PCR protocols, ed. 1. Academic Press, Inc., San Diego, 1990, p. 153.","edition":"1"},{"key":"BF03347774_CR26","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1093\/nar\/13.9.3131","volume":"13","author":"RM Myers","year":"1985","unstructured":"Myers R.M., Fischer S.G., Lerman L.S., Maniatis T. Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acid Res. 13: 3131, 1985.","journal-title":"Nucleic Acid Res."},{"key":"BF03347774_CR27","doi-asserted-by":"crossref","first-page":"8405","DOI":"10.1073\/pnas.88.19.8405","volume":"88","author":"A-L Borresen","year":"1991","unstructured":"Borresen A-L., Hovig E., Smith-Sorensen B., Malkin D., Lystad S., Andersen T.I., Nesland J.M., Isselbacher K.J., Friend S.H. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc. Natl. Acad. Sci. USA 88: 8405, 1991.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03347774_CR28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jc.74.4.712","volume":"74","author":"K Takeda","year":"1992","unstructured":"Takeda K., Weiss R.E., Refetoff S. Rapid localization of mutations in the thyroid hormone receptor-\u00df gene by denaturing gradient gel electrophoresis in 18 families with thyroid hormone resistance. J. Clin. Endocrinol. Metab. 74: 712, 1992.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347774_CR29","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"National Cancer Insutitute sponsored study of classifications of non-Hodgkin\u2019s lymphomas. Summarydescription of a Working formulation for clinical usage The non-Hodgkin\u2019s lymphoma pathologic classification project.","year":"1982","unstructured":"National Cancer Insutitute sponsored study of classifications of non-Hodgkin\u2019s lymphomas. Summary and description of a Working formulation for clinical usage The non-Hodgkin\u2019s lymphoma pathologic classification project. Cancer 49: 2112, 1982.","journal-title":"Cancer"},{"key":"BF03347774_CR30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM199205143262002","volume":"326","author":"D Malkin","year":"1992","unstructured":"Malkin D., Jolly K.W., Barbier N., Look A.T., Friend S.H., Gebhardt M.C., Andersen T.I., Borresen A-L., Li F.P., Garber J., Strong LG. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N. Engl. J. Med. 326: 1309, 1992.","journal-title":"N. Engl. J. Med."},{"key":"BF03347774_CR31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1172\/JCI115630","volume":"89","author":"CA Felix","year":"1992","unstructured":"Felix C.A., Nau M.M., Takahashi T., Mitsudomi T., Chiba I., Poplack D.G., Reaman G.H., Cole D.E., Letterio J.J., Whang-Peng J., Knutsen T., Minna J.D. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J. Clin. Invest. 89: 640, 1992.","journal-title":"J. Clin. Invest."},{"key":"BF03347774_CR32","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI116435","volume":"91","author":"J Yeargin","year":"1993","unstructured":"Yeargin J., Cheng J., Yu A.L., Gjerset R., Bogart M., Haas M. p53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines. J. Clin. Invest. 91: 2111, 1993.","journal-title":"J. Clin. Invest."},{"key":"BF03347774_CR33","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V79.10.2701.bloodjournal79102701","volume":"79","author":"A Ichikawa","year":"1992","unstructured":"Ichikawa A., Hotta T., Takagi N., Tsushita K., Kinoshita T., Nagai H., Murakami Y., Hayashi K., Saito H. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 79: 2701, 1992.","journal-title":"Blood"},{"key":"BF03347774_CR34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0140-6736(92)90866-2","volume":"339","author":"KH Vahakangas","year":"1992","unstructured":"Vahakangas K.H., Samet J.M., Metcalf R.A. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339: 576, 1992.","journal-title":"Lancet"},{"key":"BF03347774_CR35","first-page":"1685","volume":"6","author":"R Mazars","year":"1991","unstructured":"Mazars R., Pujol P., Maudelonde T., Jeanteur P., Theillet C. p53 mutations in ovarian cancer: a late event? Oncogene 6: 1685, 1991.","journal-title":"Oncogene"},{"key":"BF03347774_CR36","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1073\/pnas.88.14.6293","volume":"88","author":"E Feinstein","year":"1991","unstructured":"Feinstein E., Cimino G., Gale R.P., Alimena G., Berthier R., Kishi K., Goldman J., Zaccaria A., Berrebi A., Canaani E. p53 in chronic myelogenous leukemia in acute phase. Proc. Natl. Acad. Sci. USA 88: 6293, 1991.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03347774_CR37","first-page":"1184","volume-title":"Werner and Ingbar\u2019s The Thyroid","author":"LE Braverman","year":"1991","unstructured":"Braverman L.E., Utiger R.D. Werner and Ingbar\u2019s The Thyroid, ed. 6. J.B. Lippincott Company, Philadelphia, 1991, p. 1184.","edition":"6"},{"key":"BF03347774_CR38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/1097-0142(19860701)58:1<100::AID-CNCR2820580118>3.0.CO;2-1","volume":"58","author":"K Aozasa","year":"1986","unstructured":"Aozasa K., Inoue A., Tajima K., Miyauchi A., Matsuzuka F, Kuma K. Malignant lymphoma of the thyroid gland. Analysis of 79 patients with emphasis on histologic prognostic factors. Cancer 58: 100, 1986.","journal-title":"Cancer"},{"key":"BF03347774_CR39","first-page":"459","volume":"40","author":"K Aozasa","year":"1990","unstructured":"Aozasa K. Hashimoto\u2019s thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol. Jpn. 40: 459, 1990.","journal-title":"Acta Pathol. Jpn."},{"key":"BF03347774_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2559.1985.tb02972.x","volume":"9","author":"AM Ansocombe","year":"1985","unstructured":"Ansocombe A.M., Wright D.H. Primary, malignant lymphoma of the thyroid \u2014 a tumour of mucosa \u2014 associated lymphoid tissue: review of seventy-six cases. Histopathology 9: 81, 1985.","journal-title":"Histopathology"},{"key":"BF03347774_CR41","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","volume":"88","author":"G Gaidano","year":"1991","unstructured":"Gaidano G., Ballerini P., Gong J.Z., Inghirami G., Neri A., Newcomb C.W., Magrath I.T., Knowles D.M., Dalla-Favera R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic leukemia. Proc. Natl. Acad. Sci. USA 88: 5413, 1991.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF03347774_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/thy.1993.3.93","volume":"3","author":"F Matsuzuka","year":"1993","unstructured":"Matsuzuka F., Miyauchi A., Katayama S., Narabayashi I., Ikeda H., Kuma K., Sugawara M. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3: 93, 1993.","journal-title":"Thyroid"},{"key":"BF03347774_CR43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V81.1.128.128","volume":"81","author":"A Neri","year":"1993","unstructured":"Neri A., Baldini L., Trecca D., Cro L., Polli E., Maiolo A.T. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 81: 128, 1993.","journal-title":"Blood"},{"key":"BF03347774_CR44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","volume":"30","author":"LA Donehower","year":"1992","unstructured":"Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr, Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontanous tumours. Nature 30: 215, 1992.","journal-title":"Nature"},{"key":"BF03347774_CR45","first-page":"839","volume":"5","author":"P Jonveaux","year":"1991","unstructured":"Jonveaux P., Berger R. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia. Leukemia 5: 839, 1991.","journal-title":"Leukemia"},{"key":"BF03347774_CR46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74: 957, 1993.","journal-title":"Cell"},{"key":"BF03347774_CR47","first-page":"915","volume":"69","author":"T Morita","year":"1993","unstructured":"Morita T., Matsubayashi S., Tamai H., Akasu F., Yoshikawa N., Volpe R. Development of malignant lymphoma on SCID mice after the transplantation of human thyroid tissue. Folia Endocrinologica. J. 69: 915, 1993 (Abstract, in Japanese).","journal-title":"Folia Endocrinologica. J."},{"key":"BF03347774_CR48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","volume":"74","author":"LH Boise","year":"1993","unstructured":"Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597, 1993.","journal-title":"Cell"},{"key":"BF03347774_CR49","first-page":"746","volume":"68","author":"G Inghirami","year":"1993","unstructured":"Inghirami G., Szabolcs M.J., Yee H.T., Corradini P., Cesarman E., Knowles D.M. Detection of immunoglobulin gene rearrangement of B cell nonHodgkin\u2019s lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab. Invest. 68: 746, 1993.","journal-title":"Lab. Invest."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347774.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347774\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T07:00:24Z","timestamp":1597647624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["BF03347774"],"URL":"https:\/\/doi.org\/10.1007\/bf03347774","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}